Homepage
Strategic Summary
Project lifeQmed is based on the existing solution-QS2 database-patient registries in the fields of cardiology. This solution is well-established on the market for more than 15 years and achieving positive operational cashflow. What makes this solution unique is more than 200 000 complete individual data sets with 100 percent market share in cardiology in Austria with the possibility to scale to international markets, cover the whole patient journey from prevention over surgery up to aftercare.
Due to this fundament and high demand on the market, we decided to expand the product into outcome measurement in the cardiological patient journey. The expansion is led by highly experienced and reputable experts and in cooperation with the MEDICAL UNIVERSITY VIENNA and based on VALUE-BASED-CARE principles by HARVARD BUSINESS SCHOOL. The project has a potential to significantly impact current cardiological delivery in Europe as it guides to implement a model that delivers high-quality care with optimal medical outcomes for patients, while increasing efficiency for the healthcare system.
In next stages farther international extension options into other clinical and Big Data solutions such as research databases on demand and data-driven scientific services with added value for patients but also R&D departments in the pharmaceutical and diagnostics industries.
KEY STAKEHOLDERS
- Medical University of Vienna is among top 30 most reputable medical universities in the world.
- S2 engineering is developing software products exclusively for the healthcare sector for more than 20 years. They are the market leader for statistics-based quality assurance software in cardiac and vascular surgery in Austria.
- AQUILIA HEALTH is developing international projects in healthcare and managing digital health initiatives.
- LifeQMed is based on the value based care concept developed by